US10772933B2ActiveUtilityA1

Medicament for treating pulmonary tuberculosis

53
Assignee: SHANDONG ZHONGHAI PHARMACEUTICAL CO LTDPriority: Jan 29, 2016Filed: Jan 20, 2017Granted: Sep 15, 2020
Est. expiryJan 29, 2036(~9.5 yrs left)· nominal 20-yr term from priority
Inventors:Baozhen XuQian ChengLong Cheng
A61K 36/03A61K 36/315A61K 36/05A61K 36/04A61K 36/428A61K 31/715A61K 36/02A61P 31/06A61K 31/351A61K 36/8945A61K 35/748A61K 38/168A61K 36/195A61K 31/7012A61K 36/704A61K 38/02A61K 2300/00
53
PatentIndex Score
0
Cited by
24
References
1
Claims

Abstract

A medicament for use in treating tuberculosis, the medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A medicament for use in treating tuberculosis, comprising: a marine algae glycoprotein, indigo naturalis, dioscorea nipponica, and glucuronic acid in a ratio of 1:5:6:1 by weight,
 wherein, the marine algae glycoprotein is obtained from  Nostoc flagelliforme , and comprises 26% saccharide and 74% protein by weight with a molecular weight of 8 kDa.

Join the waitlist — get patent alerts

Track US10772933B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.